Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis

Authors:

Abstract
1. Sarcomas are rare and heterogeneous mesenchymal malignancies, constituting approximately 1% of adult cancers [1] and an even larger proportion of pediatric cancers [2], with a vast array of hist...

This publication has 65 references indexed in Scilit: